neostigmine has been researched along with Body Weight in 24 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to assess the effects of neostigmine on the postoperative ileus and the healing of colon anastomoses." | 7.77 | The effect of neostigmine on postoperative ileus and the healing of colon anastomoses. ( Durgun, V; Ekci, B; Emirleroglu, M, 2011) |
| " In the present study, we tested the effects of a cholinesterase inhibitor, neostigmine, and a muscarinic cholinergic agonist, pilocarpine, on cardiac hypertrophy and TNF alpha levels during pressure overload." | 7.74 | Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload. ( Freeling, J; LaCroix, C; Li, YF; Wattier, K, 2008) |
| "The purpose of this study was to compare neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients." | 7.73 | Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients. ( Masaki, G; Ogawa, S; Suzuki, T, 2006) |
| " We also examined if dosing regimens reflect current practice guidelines of using ideal body weight (IBW) for NMB agents and total body weight (TBW) for neostigmine." | 3.83 | Observational study on patterns of neuromuscular blockade reversal. ( Devine, S; Dubovoy, T; Housey, M; Kheterpal, S, 2016) |
| "The aim of this study was to assess the effects of neostigmine on the postoperative ileus and the healing of colon anastomoses." | 3.77 | The effect of neostigmine on postoperative ileus and the healing of colon anastomoses. ( Durgun, V; Ekci, B; Emirleroglu, M, 2011) |
| " Ten items (age, body weight, sex, duration of general anesthesia, use of propofol, use of sevoflurane, use of nitrous oxide, use of neostigmine, treatment accompanied with bleeding, and transfusion volume) were selected as risk factors for PONV." | 3.77 | Risk factors for nausea and vomiting after day care general anesthesia in mentally challenged patients undergoing dental treatment. ( Ichinohe, T; Kaneko, Y; Miyata, M; Nakata, E; Yumura, J, 2011) |
| " In the present study, we tested the effects of a cholinesterase inhibitor, neostigmine, and a muscarinic cholinergic agonist, pilocarpine, on cardiac hypertrophy and TNF alpha levels during pressure overload." | 3.74 | Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload. ( Freeling, J; LaCroix, C; Li, YF; Wattier, K, 2008) |
| "The purpose of this study was to compare neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients." | 3.73 | Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients. ( Masaki, G; Ogawa, S; Suzuki, T, 2006) |
| "To investigate the relationship between total body weight (TBW) or body mass index (BMI) and atracurium reversal time." | 3.70 | Antagonism of atracurium-induced block in obese patients. ( Kirkegaard-Nielsen, H; Lindholm, P; Petersen, HS; Severinsen, IK, 1998) |
| " Consequently, incorrect dosing will increase the rate of perioperative complications." | 2.46 | Perioperative pharmacology in morbid obesity. ( Lemmens, HJ, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (58.33) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubovoy, T | 1 |
| Housey, M | 1 |
| Devine, S | 1 |
| Kheterpal, S | 1 |
| Lemmens, HJ | 1 |
| Emirleroglu, M | 1 |
| Ekci, B | 1 |
| Durgun, V | 1 |
| Yumura, J | 1 |
| Nakata, E | 1 |
| Miyata, M | 1 |
| Ichinohe, T | 1 |
| Kaneko, Y | 1 |
| Suzuki, T | 1 |
| Masaki, G | 1 |
| Ogawa, S | 1 |
| Freeling, J | 1 |
| Wattier, K | 1 |
| LaCroix, C | 1 |
| Li, YF | 1 |
| Harper, KW | 1 |
| Bali, IM | 1 |
| Gibson, FM | 1 |
| Carlisle, R | 1 |
| Black, IH | 1 |
| Grainger, DJ | 1 |
| Dundee, JW | 1 |
| Yaksh, TL | 1 |
| Grafe, MR | 1 |
| Malkmus, S | 1 |
| Rathbun, ML | 1 |
| Eisenach, JC | 1 |
| Nielsen, HK | 1 |
| May, O | 1 |
| Kirkegaard-Nielsen, H | 1 |
| Lindholm, P | 1 |
| Petersen, HS | 1 |
| Severinsen, IK | 1 |
| García-Olmo, DC | 1 |
| García-Rivas, M | 1 |
| García-Olmo, D | 1 |
| Hodgson, J | 1 |
| Lennon, VA | 1 |
| Lindstrom, JM | 1 |
| Seybold, ME | 1 |
| Deshpande, SS | 1 |
| Viana, GB | 1 |
| Kauffman, FC | 1 |
| Rickett, DL | 1 |
| Albuquerque, EX | 1 |
| Taniguchi, A | 1 |
| Okuda, H | 1 |
| Oseko, F | 1 |
| Nagata, I | 1 |
| Kono, T | 1 |
| Tsujita, T | 1 |
| Kataoka, K | 1 |
| Imura, H | 1 |
| Komesaroff, D | 1 |
| Field, JE | 1 |
| Dechêne, JP | 1 |
| Desrosiers, R | 1 |
| Bédard, O | 1 |
| Telivuo, L | 1 |
| Ertama, P | 1 |
| Aalto-Setälä, M | 1 |
| Appelqvist, R | 1 |
| Kaljunen, A | 1 |
| Karhunen, U | 1 |
| Nuuttila, K | 1 |
| Welling, I | 1 |
| Hodgson, WJ | 1 |
| Havia, T | 1 |
| Klossner, J | 1 |
| Buckley, GA | 1 |
| Heading, CE | 1 |
| Bridenbaugh, PO | 1 |
| Churchll-Davidson, HC | 1 |
| Nakano, S | 1 |
| Tipton, CM | 1 |
| Barnard, RJ | 1 |
| Tharp, GD | 1 |
1 review available for neostigmine and Body Weight
| Article | Year |
|---|---|
Perioperative pharmacology in morbid obesity.
Topics: Analgesics, Opioid; Anesthetics; Anesthetics, Inhalation; Animals; Body Mass Index; Body Weight; Cho | 2010 |
2 trials available for neostigmine and Body Weight
| Article | Year |
|---|---|
[The optimal administration time for neostigmine following atracurium blockade. Kinetics of antagonists].
Topics: Adult; Aging; Anesthesia; Atracurium; Body Weight; Electric Stimulation; Female; Humans; Neostigmine | 1994 |
A clinical study of pancuronium, a new muscular relaxant for abdominal surgery.
Topics: Abdomen; Adolescent; Adult; Age Factors; Aged; Androstanes; Anesthesia; Atropine; Body Weight; Clini | 1972 |
21 other studies available for neostigmine and Body Weight
| Article | Year |
|---|---|
Observational study on patterns of neuromuscular blockade reversal.
Topics: Airway Extubation; Body Weight; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; | 2016 |
The effect of neostigmine on postoperative ileus and the healing of colon anastomoses.
Topics: Anastomosis, Surgical; Animals; Body Weight; Cholinesterase Inhibitors; Colon; Dietary Proteins; Fem | 2011 |
Risk factors for nausea and vomiting after day care general anesthesia in mentally challenged patients undergoing dental treatment.
Topics: Adolescent; Adult; Age Factors; Ambulatory Surgical Procedures; Anesthesia, Dental; Anesthesia, Gene | 2011 |
Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients.
Topics: Adult; Body Mass Index; Body Weight; Cholinesterase Inhibitors; Female; Humans; Middle Aged; Neostig | 2006 |
Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload.
Topics: Animals; Animals, Newborn; Body Weight; Cardiomegaly; Cells, Cultured; Constriction, Pathologic; Dru | 2008 |
Reversal of neuromuscular block. Heart rate changes with slow injection of neostigmine and atropine mixtures.
Topics: Adult; Atropine; Body Weight; Female; Heart Rate; Humans; Neostigmine; Neuromuscular Blocking Agents | 1984 |
Studies on the safety of chronically administered intrathecal neostigmine methylsulfate in rats and dogs.
Topics: Animals; Arousal; Behavior, Animal; Blood Pressure; Body Temperature; Body Weight; Cerebrospinal Flu | 1995 |
Antagonism of atracurium-induced block in obese patients.
Topics: Adult; Anesthetics, Inhalation; Anesthetics, Intravenous; Atracurium; Body Mass Index; Body Weight; | 1998 |
Does neostigmine have a deleterious effect on the resistance of colonic anastomoses?
Topics: Anastomosis, Surgical; Animals; Body Weight; Cecum; Cholinergic Agents; Colon; Female; Gastrointesti | 1998 |
Effect of lactulose on rabbits fed on a low residue diet.
Topics: Animals; Body Weight; Colon; Diet; Disaccharides; Feces; Gastrointestinal Motility; Hydrogen-Ion Con | 1975 |
Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.
Topics: Acetylcholine; Animals; Autoantibodies; Autoimmune Diseases; Body Weight; Disease Models, Animal; El | 1975 |
Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.
Topics: Acetylcholinesterase; Action Potentials; Animals; Atropine; Body Weight; Brain; Brain Chemistry; Cho | 1986 |
Regional differences in carboxylesterase activity between human subcutaneous and omental adipose tissue.
Topics: Adipose Tissue; Adult; Aged; Body Weight; Butyrates; Carboxylesterase; Carboxylic Ester Hydrolases; | 1985 |
Pancuronium bromide: a new non-depolarizing muscle relaxant.
Topics: Androstanes; Atropine; Body Weight; Histamine Release; Humans; Hypertension; Hypothermia, Induced; I | 1969 |
Clinical study of pancuronium bromide as a neuromuscular blocking agent in anaesthesia.
Topics: Adult; Androstanes; Anesthesia; Atropine; Blood Pressure; Body Weight; Female; Heart Rate; Humans; I | 1971 |
An interim report on the production of colonic diverticula in the rabbit.
Topics: Animals; Body Weight; Bread; Butter; Chloralose; Colon; Constipation; Diet; Disease Models, Animal; | 1972 |
The effect of low-residue diet on the canine colonic wall.
Topics: Animals; Body Weight; Cell Nucleus; Colon; Colon, Sigmoid; Diet; Dogs; Feces; Female; Gastrointestin | 1971 |
The effects of prolonged neostigmine treatment.
Topics: Adaptation, Physiological; Animals; Body Weight; Cholinesterases; Drug Tolerance; Male; Neostigmine; | 1971 |
Response to tubocurarine chloride and its reversal by neostigmine methylsulfate in man.
Topics: Adult; Aged; Body Weight; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Junction; Ti | 1968 |
Some physiological observations on the exocrine pancreas. The effects of some agents on pancreatic secretion.
Topics: Acetazolamide; Animals; Body Weight; Cats; Cholecystokinin; Dogs; Exocrine Glands; Furosemide; Gastr | 1968 |
Cholinesterase activity in trained and nontrained rats.
Topics: Acetylcholine; Animals; Atropine; Body Weight; Bradycardia; Butyrates; Cholinesterases; Conditioning | 1966 |